1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Aging, Premature: new trials by email Literature Review of Aging, Premature trials Research Report on Aging, Premature
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders Dasatinib, quercetin - Schizophrenia, Treatment Resistant Depression | Phase 2 | Active not recruiting | Washington University School of Medicine | 40 | 2023-07-01 | 2026-04-21 |
Depressive Disorder, Treatment-Resistant (1) · Schizophrenia (1)
Depressive Disorder (1) · Mental Disorders (1) · Mood Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Signs and Symptoms (1)
Washington University School of Medicine (1)
United States (1)
Eric Lenze, MD (1)